Voyager Therapeutics (VYGR) Change in Acquisitions & Divestments (2016 - 2026)
Voyager Therapeutics' Change in Acquisitions & Divestments history spans 9 years, with the latest figure at $118.8 million for Q1 2025.
- On a quarterly basis, Change in Acquisitions & Divestments rose 8.06% to $118.8 million in Q1 2025 year-over-year; TTM through Mar 2025 was $286.3 million, a 46.8% increase, with the full-year FY2025 number at $262.0 million, down 30.02% from a year prior.
- Change in Acquisitions & Divestments hit $118.8 million in Q1 2025 for Voyager Therapeutics, up from $109.9 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for VYGR hit a ceiling of $118.8 million in Q1 2025 and a floor of $22.6 million in Q2 2021.
- Historically, Change in Acquisitions & Divestments has averaged $71.6 million across 3 years, with a median of $72.5 million in 2021.
- The widest YoY moves for Change in Acquisitions & Divestments: up 50.88% in 2021, down 68.33% in 2021.
- Tracing VYGR's Change in Acquisitions & Divestments over 3 years: stood at $22.6 million in 2021, then surged by 385.72% to $109.9 million in 2024, then grew by 8.06% to $118.8 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for VYGR at $118.8 million in Q1 2025, $109.9 million in Q1 2024, and $22.6 million in Q2 2021.